Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Zadaxin plus DTIC improves survival in stage IV malignant melanoma

Jan. 2, 2007

Oncolytics Biotech begins new Reolysin studies

Jan. 2, 2007

ABT-737 sensitizes AML cells to Flt3 inhibitor

Jan. 2, 2007

Preliminary findings from three Telcyta phase III studies

Dec. 29, 2006

New phase II trial studies XL-880 in patients with gastric cancer

Dec. 29, 2006

YM partners with TTY in Taiwan for tesmilifene in hepatic cancer

Dec. 29, 2006

Data finalized from phase II study of talabostat plus docetaxel in NSCLC

Dec. 29, 2006

New phase II trial investigates SNS-595 in ovarian cancer

Dec. 29, 2006

Introgen obtains license to patent applications covering INGN-241 uses

Dec. 29, 2006

MK-0457 begins pivotal phase II study in treatment-resistant advanced leukemias

Dec. 29, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 23, 2026.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.
In vivo click ADCs could address tumor heterogeneity
BioWorld
Researchers at Washington University in St. Louis have used click chemistry to link a second antibody to a pre-existing antibody-drug conjugate (ADC) in vivo. In...